These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8050827)

  • 1. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: evidence of a functional IGF-II-mediated autocrine loop.
    Lahm H; Amstad P; Wyniger J; Yilmaz A; Fischer JR; Schreyer M; Givel JC
    Int J Cancer; 1994 Aug; 58(3):452-9. PubMed ID: 8050827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells.
    De Leon DD; Wilson DM; Powers M; Rosenfeld RG
    Growth Factors; 1992; 6(4):327-36. PubMed ID: 1340210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha.
    Lahm H; Suardet L; Laurent PL; Fischer JR; Ceyhan A; Givel JC; Odartchenko N
    Br J Cancer; 1992 Mar; 65(3):341-6. PubMed ID: 1558785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells.
    Zarrilli R; Pignata S; Romano M; Gravina A; Casola S; Bruni CB; Acquaviva AM
    Cell Growth Differ; 1994 Oct; 5(10):1085-91. PubMed ID: 7848910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC).
    Scharf JG; Schmidt-Sandte W; Pahernik SA; Ramadori G; Braulke T; Hartmann H
    Carcinogenesis; 1998 Dec; 19(12):2121-8. PubMed ID: 9886566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.
    Giuliano M; Vento R; Lauricella M; Calvaruso G; Carabillo M; Tesoriere G
    Eur J Biochem; 1996 Mar; 236(2):523-32. PubMed ID: 8612625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.
    Baier TG; Jenne EW; Blum W; Schönberg D; Hartmann KK
    Leuk Res; 1992 Aug; 16(8):807-14. PubMed ID: 1326686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
    J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.
    Elizalde PV; Lanari C; Molinolo AA; Guerra FK; Balañá ME; Simian M; Iribarren AM; Charreau EH
    J Steroid Biochem Mol Biol; 1998 Nov; 67(4):305-17. PubMed ID: 9883987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
    Zhang Y; Zhang Y
    Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of insulin-like growth factors IGF-I and IGF-II, and their receptors during the growth and megakaryocytic differentiation of K562 cells.
    Aro AL; Savikko J; Pulkkinen V; von Willebrand E
    Leuk Res; 2002 Sep; 26(9):831-7. PubMed ID: 12127559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
    Thompson MA; Cox AJ; Whitehead RH; Jonas HA
    Endocrinology; 1990 Jun; 126(6):3033-42. PubMed ID: 1693565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.